Xvivo Perfusion AB (publ)
OTC: XVIPF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Christoffer Rosenblad
- Employees
- 193
- Headquarters
- Gothenburg, Sweden
- IPO year
- 2014
- Market cap
- $913.5M
- Website
- https://www.xvivoperfusion.com
Loading XVIPF…
Loading profile data…Frequently asked questions about XVIPF
What does Xvivo Perfusion AB (publ) (XVIPF) do?
Xvivo Perfusion AB (publ) is a medical technology company dedicated to advancing transplantation medicine. The firm specializes in pioneering solutions for the preservation and perfusion of organs, tissues, and cells, essential for successful transplant procedures. With a significant international presence, Xvivo Perfusion operates across divers...
Where does XVIPF trade?
Xvivo Perfusion AB (publ) (XVIPF) trades on the Other OTC.
What sector is XVIPF in?
Xvivo Perfusion AB (publ) (XVIPF) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Xvivo Perfusion AB (publ)?
Christoffer Rosenblad is the chief executive officer of Xvivo Perfusion AB (publ) (XVIPF).
Where is Xvivo Perfusion AB (publ) headquartered?
Xvivo Perfusion AB (publ) is headquartered in Sweden.
Does XVIPF pay a dividend?
Xvivo Perfusion AB (publ) (XVIPF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did XVIPF go public?
Xvivo Perfusion AB (publ) (XVIPF) completed its initial public offering in 2014.